PubMed Health⌕ Search

Biomedical subjects

C E Machamer

Publications and source records attributed to C E Machamer.

41 records · Page 3Linked to original sources

Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.

The biosynthesis and glycosylation of the invariant (I) chain associated with HLA-DR alpha-beta chain complexes has been examined in human B lymphoblastoid cell lines. Two-dimensional polyacrylamide gel electrophoresis of HLA-DR immune precipitates from extracts of metabolically labeled cells demonstrated a processes form of the I chain, called Ip, which consists of a series of spots beginning near the basic I chain spot and ending near the acidic alpha spots. Pulse/chase labeling yielded information on the kinetics of processing of the invariant chain, as well as the finding that the association of Ip with alpha-beta chain complexes appears to be transient. Neuraminidase treatment of immune precipitates confirmed that Ip was a form of the I chain containing up to eight sialic acid residues. Labeling in the presence of tunicamycin suggested the presence of both N-linked and O-linked oligosaccharide units on the invariant chain. This processing pattern does not appear to be an artifact of B cell lines; it was seen in peripheral blood lymphocytes, freshly purified monocytes, and in an interleukin 2-dependent continuous T cell line that expressed HLA-DR. In addition, there appears to be a free pool of the invariant chain and its processed form that is not found associated with DR alpha and beta chains.

B-Lymphocytes↗

Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosis.

Immunoprecipitation methods were used to analyze sera and cerebrospinal fluids from patients with multiple sclerosis for measles virus-specific antibodies. The sera contained antibodies against all virus antigens except the matrix polypeptide. Of the nine cerebrospinal fluids investigated, two contained undetectable levels of measles-specific antibodies, four contained antibodies against the nucleocapsid and another internal antigen, and three contained antibodies against the surface antigens as well as the internal antigens.

Antibodies, Viral↗

Antibodies against the measles matrix polypeptide after clinical infection and vaccination.

Sera from patients exposed to measles virus were investigated for the presence of antibodies against each of the viral antigens. All sera with measurable neutralizing titers contained antibodies against the two surface proteins (the glycoprotein and fusion protein), the nucleocapsid protein, and one of the internal proteins (P2). However, only sera from individuals with clinical symptoms of measles infection (natural measles and atypical measles) contained antibodies against the measles virus matrix protein. Levels of matrix-specific antibodies were highest in patients with atypical measles infection.

Antibodies, Viral↗

Measles virus nucleocapsids: large-scale purification and use in radioimmunoassays.

Nucleocapsids in quantities approaching 1 mg were purified from 109 measles virus-infected cells. They contained one polypeptide species with a molecular weight of 59,000. Antiserum was raised in rabbits against purified nucleocapsids and used in a competitive radioimmunoassay. Because of their instability, purified nucleocapsids were not suitable for use in such an assay. Instead partially purified nucleocapsids from HEp-2 cells persistently infected with measles virus and labeled in vitro with [35S]methionine were used as the source of radioactive antigen. The radioimmunoassay thus developed measured less than 5 ng of nucleocapsids in infected cells.

Animals↗